Zobrazeno 1 - 10
of 101
pro vyhledávání: '"M den Hartog"'
Computational Chemistry Strategies to Investigate the Antioxidant Activity of Flavonoids—An Overview
Publikováno v:
Molecules, Vol 29, Iss 11, p 2627 (2024)
Despite several decades of research, the beneficial effect of flavonoids on health is still enigmatic. Here, we focus on the antioxidant effect of flavonoids, which is elementary to their biological activity. A relatively new strategy for obtaining a
Externí odkaz:
https://doaj.org/article/3f8bfa9cb8ee4121b10df21c8c36d3ed
Autor:
Yvon M. den Hartog, Gerjon Hannink, Nick T. van Dasselaar, Nina M. Mathijssen, Stephan B. Vehmeijer
Publikováno v:
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-7 (2017)
Abstract Background In our hospital a fast-track setting including a multimodal pain protocol is used for total hip arthroplasty (THA). Despite this multimodal pain protocol there is still a large range in reported postoperative pain between patients
Externí odkaz:
https://doaj.org/article/3d354d1d15a74e5aa9eb3f9626125e75
Autor:
Pieter Bas de Witte, Christiaan J A van Bergen, Babette L de Geest, Floor Willeboordse, Joost H van Linge, Yvon M den Hartog, Magritha (Margret) M H P Foreman-van Drongel, Renske M Pereboom, Simon G F Robben, Bart J Burger, M Adhiambo Witlox, Melinda M E H Witbreuk
Publikováno v:
EFORT Open Reviews. 7(8):542-553
Background and purpose Diagnostics and treatment of developmental dysplasia of the hip (DDH) are highly variable in clinical practice. To obtain more uniform and evidence-based treatment pathways, we developed the ‘Dutch guideline for DDH in childr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Christiaan J A van Bergen, Pieter Bas de Witte, Floor Willeboordse, Babette L de Geest, Magritha (Margret) M H P Foreman-van Drongelen, Bart J Burger, Yvon M den Hartog, Joost H van Linge, Renske M Pereboom, Simon G F Robben, M Adhiambo Witlox, Melinda M E H Witbreuk
Publikováno v:
EFORT Open Reviews, 7(7), 498-505. British Editorial Society of Bone and Joint Surgery
van Bergen, C J A, de Witte, P B, Willeboordse, F, de Geest, B L, Drongelen, M M H P F, Burger, B J, Hartog, Y M D, van Linge, J H, Pereboom, R M, Robben, S G F, Witlox, M A & Witbreuk, M M E H 2022, ' Treatment of centered developmental dysplasia of the hip under the age of 1 year : an evidence-based clinical practice guideline-Part 1 ', EFORT Open Reviews, vol. 7, no. 7, pp. 498-505 . https://doi.org/10.1530/EOR-21-0125
EFORT Open Reviews, 7(7), 498-505. BIOSCIENTIFICA LTD
van Bergen, C J A, de Witte, P B, Willeboordse, F, de Geest, B L, Drongelen, M M H P F, Burger, B J, Hartog, Y M D, van Linge, J H, Pereboom, R M, Robben, S G F, Witlox, M A & Witbreuk, M M E H 2022, ' Treatment of centered developmental dysplasia of the hip under the age of 1 year : an evidence-based clinical practice guideline-Part 1 ', EFORT Open Reviews, vol. 7, no. 7, pp. 498-505 . https://doi.org/10.1530/EOR-21-0125
EFORT Open Reviews, 7(7), 498-505. BIOSCIENTIFICA LTD
Despite the high incidence of developmental dysplasia of the hip (DDH), treatment is very diverse. Therefore, the Dutch Orthopedic Society developed a clinical practice guideline with recommendations for optimal and uniform treatment of DDH. This art
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eleonora L. Swart, Anthe S Zandvliet, N. Harry Hendrikse, Christel C. L. M. Boons, Yvonne M den Hartog, Jeroen Janssen, Jacqueline G. Hugtenburg, René M Vos
Publikováno v:
European Journal of Haematology
European Journal of Haematology, 105(2), 148-155. Wiley-Blackwell
Boons, C C L M, den Hartog, Y M, Janssen, J J W M, Zandvliet, A S, Vos, R M, Swart, E L, Hendrikse, N H & Hugtenburg, J G 2020, ' Food-effect study of nilotinib in chronic myeloid leukaemia (NiFo study) : Enabling dose reduction and relief of treatment burden ', European Journal of Haematology, vol. 105, no. 2, pp. 148-155 . https://doi.org/10.1111/ejh.13418
European Journal of Haematology, 105(2), 148-155. Wiley-Blackwell
Boons, C C L M, den Hartog, Y M, Janssen, J J W M, Zandvliet, A S, Vos, R M, Swart, E L, Hendrikse, N H & Hugtenburg, J G 2020, ' Food-effect study of nilotinib in chronic myeloid leukaemia (NiFo study) : Enabling dose reduction and relief of treatment burden ', European Journal of Haematology, vol. 105, no. 2, pp. 148-155 . https://doi.org/10.1111/ejh.13418
OBJECTIVES: Taking advantage of its food-dependent bioavailability, the present study investigated the effect of a reduced dose taken with real-life meals on the pharmacokinetics (PK) of nilotinib in chronic myeloid leukaemia (CML) patients.METHODS:
Autor:
Sabine Haggenburg, Birgit I. Lissenberg-Witte, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J. E. Haverkate, Dennis M. de Rooij, Johan van Meerloo, Jacqueline Cloos, Neeltje A. Kootstra, Dorine Wouters, Suzanne S. Weijers, Ester M. M. van Leeuwen, Hetty J. Bontkes, Saïda Tonouh-Aajoud, Mirjam H. M. Heemskerk, Rogier W. Sanders, Elianne Roelandse-Koop, Quincy Hofsink, Kazimierz Groen, Lucia Çetinel, Louis Schellekens, Yvonne M. den Hartog, Belle Toussaint, Iris M. J. Kant, Thecla Graas, Emma de Pater, Willem A. Dik, Marije D. Engel, Cheyenne R. N. Pierie, Suzanne R. Janssen, Edith van Dijkman, Meliawati Poniman, Judith A. Burger, Joey H. Bouhuijs, Gaby Smits, Nynke Y. Rots, Sonja Zweegman, Arnon P. Kater, Tom van Meerten, Pim G. N. J. Mutsaers, Jaap A. van Doesum, Annoek E. C. Broers, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof
Publikováno v:
Blood Advances, 6(5), 1537-1546. ELSEVIER
Blood Advances
Haggenburg, S, Lissenberg-Witte, B I, van Binnendijk, R S, den Hartog, G, Bhoekhan, M S, Haverkate, N J E, de Rooij, D M, van Meerloo, J, Cloos, J, Kootstra, N A, Wouters, D, Weijers, S S, van Leeuwen, E M M, Bontkes, H J, Tonouh-Aajoud, S, Heemskerk, M H M, Sanders, R W, Roelandse-Koop, E, Hofsink, Q, Groen, K, Çetinel, L, Schellekens, L, den Hartog, Y M, Toussaint, B, Kant, I M J, Graas, T, de Pater, E, Dik, W A, Engel, M D, Pierie, C R N, Janssen, S R, van Dijkman, E, Poniman, M, Burger, J A, Bouhuijs, J H, Smits, G, Rots, N Y, Zweegman, S, Kater, A P, van Meerten, T, Mutsaers, P G N J, van Doesum, J A, Broers, A E C, van Gils, M J, Goorhuis, A, Rutten, C E, Hazenberg, M D & Nijhof, I S 2022, ' Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients ', BLOOD ADVANCES, vol. 6, no. 5, pp. 1537-1546 . https://doi.org/10.1182/bloodadvances.2021006917
BLOOD ADVANCES, 6(5), 1537-1546. American Society of Hematology
Blood advances, 6(5), 1537-1546. American Society of Hematology
Blood Advances, 6(5), 1537-1546. AMER SOC HEMATOLOGY
Blood Advances
Haggenburg, S, Lissenberg-Witte, B I, van Binnendijk, R S, den Hartog, G, Bhoekhan, M S, Haverkate, N J E, de Rooij, D M, van Meerloo, J, Cloos, J, Kootstra, N A, Wouters, D, Weijers, S S, van Leeuwen, E M M, Bontkes, H J, Tonouh-Aajoud, S, Heemskerk, M H M, Sanders, R W, Roelandse-Koop, E, Hofsink, Q, Groen, K, Çetinel, L, Schellekens, L, den Hartog, Y M, Toussaint, B, Kant, I M J, Graas, T, de Pater, E, Dik, W A, Engel, M D, Pierie, C R N, Janssen, S R, van Dijkman, E, Poniman, M, Burger, J A, Bouhuijs, J H, Smits, G, Rots, N Y, Zweegman, S, Kater, A P, van Meerten, T, Mutsaers, P G N J, van Doesum, J A, Broers, A E C, van Gils, M J, Goorhuis, A, Rutten, C E, Hazenberg, M D & Nijhof, I S 2022, ' Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients ', BLOOD ADVANCES, vol. 6, no. 5, pp. 1537-1546 . https://doi.org/10.1182/bloodadvances.2021006917
BLOOD ADVANCES, 6(5), 1537-1546. American Society of Hematology
Blood advances, 6(5), 1537-1546. American Society of Hematology
Blood Advances, 6(5), 1537-1546. AMER SOC HEMATOLOGY
Vaccination guidelines for patients treated for hematological diseases are typically conservative. Given their high risk for severe COVID-19, it is important to identify those patients that benefit from vaccination. We prospectively quantified serum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910d395eeba8d201206c2b0c53c0f7f9
https://hdl.handle.net/1887/3566457
https://hdl.handle.net/1887/3566457
Autor:
Daniëlle M P H J Boesten, Alvin Berger, Peter de Cock, Hua Dong, Bruce D Hammock, Gertjan J M den Hartog, Aalt Bast
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65741 (2013)
Diabetes is characterized by hyperglycemia and development of vascular pathology. Endothelial cell dysfunction is a starting point for pathogenesis of vascular complications in diabetes. We previously showed the polyol erythritol to be a hydroxyl rad
Externí odkaz:
https://doaj.org/article/f8f852351a1e4f829913b185859d91ea